The General Data Protection Law provides for the protection of personal data and has significant implications in numerous areas, including in healthcare. In the health field, due to the relevant amount of sensitive data containing information on health, it is required caution from the treatment agents, since its processing is more likely to cause a high risk to the rights of the data subjects. In this regard, the art. 35 of the General Data Protection Regulation, the European legislation on the protection of personal data, determines that the carrying out of Impact Assessments is mandatory, which is not evident in the Brazilian legislation. Through exploratory research, based on a bibliographic and documentary survey, the importance of these assessments by health institutions in the treatment of sensitive data is investigated, so as to attest not only compliance with legislation, but also with stipulations present in deontological codes that value secrecy, privacy and confidentiality in doctor-patient relationship. At first, general aspects of the Brazilian law and a comparative perspective regarding the European one are discussed. Secondly, it exposes the association between treatment of sensitive data and confidentiality in healthcare. It concludes that it is important to carry out the Impact Assessment on sensitive data, an occasion in which the European experience of risk-based methodology is considered.
Vetis Zaganelli, M., Binda Filho, D. (2022). La Llei General de Protecció de Dades i les seves implicacions per a la salut. REVISTA DE BIOÉTICA Y DERECHO(54), 215-232 [10.1344/rbd2021.54.36005].
La Llei General de Protecció de Dades i les seves implicacions per a la salut
Binda Filho, DL
2022
Abstract
The General Data Protection Law provides for the protection of personal data and has significant implications in numerous areas, including in healthcare. In the health field, due to the relevant amount of sensitive data containing information on health, it is required caution from the treatment agents, since its processing is more likely to cause a high risk to the rights of the data subjects. In this regard, the art. 35 of the General Data Protection Regulation, the European legislation on the protection of personal data, determines that the carrying out of Impact Assessments is mandatory, which is not evident in the Brazilian legislation. Through exploratory research, based on a bibliographic and documentary survey, the importance of these assessments by health institutions in the treatment of sensitive data is investigated, so as to attest not only compliance with legislation, but also with stipulations present in deontological codes that value secrecy, privacy and confidentiality in doctor-patient relationship. At first, general aspects of the Brazilian law and a comparative perspective regarding the European one are discussed. Secondly, it exposes the association between treatment of sensitive data and confidentiality in healthcare. It concludes that it is important to carry out the Impact Assessment on sensitive data, an occasion in which the European experience of risk-based methodology is considered.File | Dimensione | Formato | |
---|---|---|---|
Vetis Zaganelli-2022-Rev Bioética Derecho-VoR.pdf
accesso aperto
Tipologia di allegato:
Publisher’s Version (Version of Record, VoR)
Licenza:
Creative Commons
Dimensione
361.34 kB
Formato
Adobe PDF
|
361.34 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.